News | Analytics Software | October 30, 2015

Societies Release Statement on the Future of Clinical Registries

Registries can support development, implementation and evaluation of performance measures

October 30, 2015 — The American College of Cardiology, the American Heart Association and The Society of Thoracic Surgeons released a new statement in early October on the future of clinical registries titled ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise.

Clinical registries are observational databases focused on clinical conditions, procedures, therapies or populations. The goal of registries is to capture data that reflect real-world clinical practice in patient populations.

“Registries are fundamental to healthcare quality and improvement,” said Deepak L. Bhatt, M.D., M.P.H., FACC, FAHA, executive director of intervention cardiovascular programs at Brigham and Women’s Hospital Heart and Vascular Center, professor of medicine at Harvard Medical School, and chair of the writing committee. “Registries can support the development, implementation and evaluation of performance measures as tools for improving patient care and communicating meaningful information to patients regarding quality.”

The statement examines the current state of clinical registries while acknowledging their future growth potential.  The authors write that while there has been an “explosion” in the number of clinical registries over the past decade, there are still broad clinical areas and specific procedures that would benefit from the creation of a dedicated registry.

“The future will likely involve some degree of integration of electronic health records and administrative data sources with registry data,” Bhatt said.

The document was published online in the Journal of the American College of Cardiology, Circulation: Cardiovascular Quality and Outcomes and The Annals of Thoracic Surgery.

For more information: www.acc.org, www.heart.org, www.sts.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now